PMC:7558914 / 768-946
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"39","span":{"begin":132,"end":140},"obj":"Species"},{"id":"44","span":{"begin":11,"end":29},"obj":"Chemical"},{"id":"45","span":{"begin":35,"end":47},"obj":"Chemical"},{"id":"46","span":{"begin":51,"end":70},"obj":"Chemical"},{"id":"67","span":{"begin":164,"end":174},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D006886"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D017963"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C558899"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":". Combined hydroxychloroquine with azithromycin or lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":164,"end":174},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":". Combined hydroxychloroquine with azithromycin or lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":2,"end":101},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":". Combined hydroxychloroquine with azithromycin or lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was"}